27.53 0.00 (0.00%)
After hours: 4:57PM EDT
|Bid||24.80 x 800|
|Ask||27.48 x 800|
|Day's range||27.23 - 28.21|
|52-week range||15.17 - 32.66|
|Beta (5Y monthly)||1.05|
|PE ratio (TTM)||N/A|
|Earnings date||04 Nov 2020 - 09 Nov 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||26.83|
The unit's acquisition, which was completed last month, created the world's second-largest company in the sector. Elanco said it started repayment of the loan that funded the Bayer Animal Health takeover. The job cuts primarily affect positions in sales and marketing, and also research and development, manufacturing and quality, the company said.
Elanco Animal Health Incorporated (NYSE:ELAN) today announced its first business restructuring just two months following the closing of its acquisition of Bayer Animal Health. The company also noted it has started to de-lever by making a $100 million payment on its term loan.
Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the Morgan Stanley 18th Annual Global Healthcare Conference on Tuesday, September 15, 2020. Jeff Simmons, president and CEO, will participate in a virtual fireside chat at 2:00 p.m. EDT.